<DOC>
	<DOC>NCT01157312</DOC>
	<brief_summary>The purpose of this study is to compare and determine the the efficacy of minimal stimulation and clomiphene citrate(CC) as the first-line treatment in infertile women with Polycystic Ovary Syndrome(PCOS).</brief_summary>
	<brief_title>Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome</brief_title>
	<detailed_description>All patients received 100 mg CC (ClomidÂ®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from day 3 of spontaneous or induced menstruation. In group A (minimal stimulation), 2 vials of highly purified uFSH , 150 IU (Fostimon; IBSA, Lugano, Switzerland, 75 IU/vial) were given IM on cycle day 9. A total of 3 cycles was offered to each group.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>PCOS No other infertility factors No previous use of ovarian stimulation drugs Congenital adrenal hyperplasia Cushing syndrome Androgen secreting tumors</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>clomiphene citrate</keyword>
	<keyword>minimal stimulation</keyword>
	<keyword>infertility treatment</keyword>
</DOC>